Shop

Showing 225–240 of 1319 results

• 

  Article: Concerning a previously published practice guidelines article

  €3.03 Add to cart
• 

  Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

  €3.03 Add to cart
• 

  Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma

  €3.03 Add to cart
• 

  Article: Congress Calendar

  €3.03 Add to cart
• 

  Article: Congress Calendar

  €3.03 Add to cart
• 

  Article: Congress highlights 2018

  €3.03 Add to cart
• 

  Article: Congress highlights 2018

  €3.03 Add to cart
• 

  Article: Congress Highlights 2018 Special,

  €3.03 Add to cart
• 

  Article: Congress highlights 2020

  €3.03 Add to cart
• 

  Article: Congress highlights 2022

  €3.03 Add to cart
• 

  Article: Congress highlights in uro-oncology

  €3.03 Add to cart
• 

  Article: Congress highlights SABCS 2021

  €3.03 Add to cart
• 

  Article: Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease

  €3.03 Add to cart
• 

  Article: Consistent superior benefit of cobimetinib/vemurafenib over vemurafenib monotherapy across mutation subtypes in BRAF-mutated advanced melanoma

  €3.03 Add to cart
• 

  Article: Consolidation durvalumab as a new standard of care for patients with limited-stage small-cell lung cancer without disease progression after concurrent chemoradiotherapy

  €3.03 Add to cart
• 

  Article: Consolidation immunotherapy for stage III non-small cell lung cancer in Belgian real-life practice

  €3.03 Add to cart